Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 December 2022
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
61
Renminbi (CNY)
17
Euro (EUR)
11
Indian rupee (INR)
4
Other currencies (CAD, DKK, GBP, HDK, SEK)
4
Swiss franc (CHF)
3
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Public (from private) companies
28
Public companies
15
Private companies
32
Funds
8
Cash and cash equivalents
15
Other assets
2
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
44
Products on the market
24
Phase II
13
Phase I
6
Preclinical
8
Phase III
5
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
25
Synthetic biology
20
Central nervous system
13
Oncology
14
Immunology/Inflammation
7
Digital Health
9
Orphan diseases
6
Medical technology / diagnostics
6
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8